POLIDOCANOL INJECTION bulk supplier for pharma manufacturers

Polidocanol Injection 0.25%, 0.5%, 1%, 2%, 3% Suppliers & Bulk Manufacturers

Available Forms: Injection

Available Strengths: 0.25%, 0.5%, 1%, 2%, 3%

Reference Brands: Asclera (USA), Aethoxysklerol (EU/UK/LATAM)

Injection contains the active constituent polidocanol. It is used in the treatment of Varicose veins of the lower extremities. Varicose veins are enlarged and twisted veins that commonly affect the veins in the legs.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Product Description:

It is caused by pressure in the veins of the lower body created by prolonged standing and walking. Varicose veins cause discomfort and aching pain; sometimes, it led to severe problems.

Polidocanol (lauromacrogol 400) is a medication widely used in dermatology and vascular treatments due to its local anesthetic, antipruritic, and sclerosing properties. It is commonly included as an active ingredient in ointments, creams, and bath additives designed to relieve itching and skin irritation associated with conditions such as eczema, dermatitis, and dry skin. By soothing the skin and reducing nerve irritation, polidocanol helps provide effective relief from persistent itching and discomfort.

In addition to its dermatological use, polidocanol is also used in medical procedures to treat vascular conditions such as varicose veins, spider veins, hemangiomas, and certain vascular malformations. In these treatments, it acts as a sclerosing agent, meaning it is injected directly into affected veins where it damages the inner lining of the blood vessel. This causes the vein to collapse, close, and eventually be reabsorbed by the body over time.

Chemically, polidocanol is produced through the ethoxylation of dodecanol, resulting in a non-ionic surfactant compound suitable for medical applications. Due to its dual role in skin care and vascular therapy, polidocanol is widely utilized in both dermatological formulations and minimally invasive vein treatment procedures.

Polidocanol Injection — third party manufacturing & bulk supply

Polidocanol Injection 0.25%, 0.5%, 1%, 2%, 3% is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Polidocanol Injection is supplied as Injection — an injectable dosage form, so the indicative MOQ is 50,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Polidocanol Injection listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Polidocanol Injection →

Back to Listing

Frequently Asked Questions

Polidocanol (lauromacrogol 400) is used for the treatment of small varicose veins and spider veins through a procedure known as sclerotherapy. The medicine is injected directly into the affected vein, where it causes controlled damage to the vein lining, leading to closure of the vein and gradual reabsorption by the body.

Polidocanol (lauromacrogol 400) is a synthetic non-ionic surfactant compound developed for medical use as a sclerosing agent. It works by damaging the inner lining of blood vessels, which results in the vein collapsing and eventually being replaced with healthy tissue.

Common trade names for polidocanol (lauromacrogol 400) include Asclera and Aethoxysklerol.

Asclera is marketed by Merz Pharmaceuticals, while Aethoxysklerol is produced by companies involved in vascular and dermatology treatments in Europe.

The generic name of Asclera is polidocanol (lauromacrogol 400).

Well-known brand names of polidocanol (lauromacrogol 400) include Asclera and Aethoxysklerol.

Polidocanol injections are manufactured in GMP-certified pharmaceutical facilities specializing in sterile injectable formulations for vascular and dermatological treatments, mainly in Europe, the United States, and other regulated markets.